Filing Details

Accession Number:
0001179110-13-003142
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-02-20 17:35:07
Reporting Period:
2013-02-15
Filing Date:
2013-02-20
Accepted Time:
2013-02-20 17:35:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1239128 W Greg Linder 1 N. Waukegan Road
North Chicago IL 60064
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2013-02-15 20,600 $0.00 150,889 No 4 A Direct
Common Shares Without Par Value Disposition 2013-02-19 2,912 $35.08 147,977 No 4 F Direct
Common Shares Without Par Value Disposition 2013-02-19 1,314 $34.76 146,663 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Acquisiton 2013-02-15 106,600 $0.00 106,600 $34.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
106,600 2014-02-15 2023-02-14 No 4 A Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares Without Par Value 4,134 Indirect Profit Sharing Trust
Footnotes
  1. These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
  2. Balance in the Abbott Laboratories Stock Retirement Trust as of February 15, 2013.
  3. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 35,534 on 2/15/2014, 35,533 on 2/15/2015, and 35,533 on 2/15/2016.